{"id":776928,"date":"2025-12-01T09:50:01","date_gmt":"2025-12-01T09:50:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=776928"},"modified":"2025-12-01T09:50:01","modified_gmt":"2025-12-01T09:50:01","slug":"neupril-reaches-one-million-customers-with-usmanufactured-methylfolate-supplements","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/neupril-reaches-one-million-customers-with-usmanufactured-methylfolate-supplements_776928.html","title":{"rendered":"Neupril Reaches One Million Customers With US-Manufactured Methylfolate Supplements"},"content":{"rendered":"
\n
\"Neupril<\/a><\/div>\n
\n
Neupril Pure Methylfolate \u2014 Manufactured in the USA in an FDA-registered, GMP-certified facility and third-party tested for purity and potency. <\/div>\n<\/div>\n<\/div>\n
Neupril, a United States-based supplement company, announces serving over one million customers with its American-manufactured methylfolate formula. All Neupril products are produced in an FDA-registered, GMP-certified facility in the USA and undergo rigorous third-party laboratory testing for potency, heavy metals, and contaminants before nationwide distribution.<\/div>\n

American-Made Supplement Company Reinforces Commitment to Domestic Production and Independent Third-Party Testing<\/strong><\/p>\n

Neupril, a health and wellness company specializing in methylfolate supplementation, has announced reaching the milestone of one million customers served while maintaining its commitment to United States-based manufacturing and comprehensive third-party quality testing.<\/p>\n

The company produces all of its liquid L-methylfolate supplements domestically in an FDA-registered, GMP-certified manufacturing facility located in the United States. This commitment to American manufacturing ensures products meet rigorous federal quality and safety standards enforced by U.S. regulatory authorities.<\/p>\n

Quality Assurance Through Third-Party Testing<\/strong><\/p>\n

Central to Neupril’s operations is a comprehensive third-party testing protocol. Every batch of Neupril supplements undergoes independent laboratory analysis before distribution to consumers. This third-party testing includes potency verification to confirm label accuracy, heavy metals screening for lead, mercury, arsenic, and cadmium, and microbial contamination testing to ensure product safety.<\/p>\n

The company’s manufacturing facility maintains Current Good Manufacturing Practice (cGMP) certification as required by the U.S. Food and Drug Administration for supplement production. This FDA-registered facility undergoes regular compliance audits and inspections to maintain its certification status.<\/p>\n

Domestic Operations and Fulfillment<\/strong><\/p>\n

All Neupril products are manufactured in the United States and shipped from American-based fulfillment centers. Domestic customers typically receive orders within three to seven business days through standard U.S. shipping carriers, with tracking information provided for all shipments.<\/p>\n

The company maintains customer support operations and offers a 30-day satisfaction guarantee on all purchases, allowing customers to return products if not satisfied.<\/p>\n

Product Formulation<\/strong><\/p>\n

Neupril’s flagship adult formula provides 15 milligrams of L-5-Methylfolate calcium salt combined with Methylcobalamin, the active form of Vitamin B12. The liquid drop format is designed for efficient absorption and ease of use.<\/p>\n

The company also manufactures Neupril Kids Pure Methylfolate, a pediatric formula with age-appropriate dosing for children ages one through eighteen. Both products are produced in the same FDA-registered, GMP-certified, and third-party tested facility.<\/p>\n

All Neupril formulations are non-GMO, vegan-friendly, and free from gluten, dairy, soy, nuts, artificial colors, and artificial preservatives.<\/p>\n

Customer Response and Company Growth<\/strong><\/p>\n

Neupril reports a 4.7-star average rating based on over 45,000 customer reviews. The company attributes its growth to consistent product quality, transparent manufacturing practices, and responsive customer service.<\/p>\n

About Methylfolate Supplementation<\/strong><\/p>\n

L-Methylfolate, also designated as 5-MTHF, represents the biologically active form of folate that circulates in the human bloodstream. Research indicates that genetic variations in the MTHFR enzyme affect folate metabolism in a significant percentage of the population. Unlike synthetic folic acid, L-methylfolate does not require enzymatic conversion and is immediately available for biological processes.<\/p>\n

About Neupril<\/strong><\/p>\n

Neupril is a United States-based health and wellness company focused on methylfolate supplementation. The company manufactures all products in an FDA-registered, GMP-certified American facility, with every batch verified through independent third-party laboratory testing. Neupril serves customers nationwide through its website at neupril.com<\/a>.<\/p>\n

For more information, visit neupril.com<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Neupril<\/a>
Contact Person:<\/strong> John Riley
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 3072155697
Address:<\/strong>5830 east 2nd street suite 7000
City:<\/strong> Casper
State:<\/strong> WY
Country:<\/strong> United States
Website:<\/strong> www.neupril.com<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Neupril Pure Methylfolate \u2014 Manufactured in the USA in an FDA-registered, GMP-certified facility and third-party tested for purity and potency. Neupril, a United States-based supplement company, announces serving over one million customers with its American-manufactured methylfolate formula. All Neupril products … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,410,406,404],"tags":[],"class_list":["post-776928","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Manufacturing-Industry","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/776928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=776928"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/776928\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=776928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=776928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=776928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}